Paperpal Prime Logo

Drug Development and Industrial Pharmacy : Impact Factor & More

eISSN: 1520-5762pISSN: 0363-9045

Key Metrics

CiteScore
5.9
H-Index
96
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Development and Industrial Pharmacy

Drug Development and Industrial Pharmacy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1974
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Development and Industrial Pharmacy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development and Industrial Pharmacy

Safety, tolerability, and pharmacokinetics of oral FM888 in healthy Chinese adults: a Phase I, randomized, double-blind, placebo-controlled study
  • 5 Aug 2026
  • Drug Development and Industrial Pharmacy
Evaluation of Compatibility of Domperidone with Selected Excipients used in Preparation of Orally Disintegrating Tablets
  • 4 Aug 2026
  • Drug Development and Industrial Pharmacy
Chemical aspects of controlled cisplatin release and apoptosis via Nerium oleander latex nano-carriers in breast cancer cells
  • 3 Aug 2026
  • Drug Development and Industrial Pharmacy
Advances in pectin-based bead formation via ionotropic gelation for enhanced drug delivery: a scoping review
  • 1 Aug 2026
  • Drug Development and Industrial Pharmacy
Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis
  • 1 Aug 2026
  • Drug Development and Industrial Pharmacy
Development and Evaluation of Rizatriptan Benzoate Orally Disintegrating Tablets for Migraine Treatment
  • 31 Jul 2026
  • Drug Development and Industrial Pharmacy
Safety, tolerability, and pharmacokinetics of oral FM888 in healthy Chinese adults: a Phase I, randomized, double-blind, placebo-controlled study
  • 5 Aug 2026
  • Drug Development and Industrial Pharmacy
Evaluation of Compatibility of Domperidone with Selected Excipients used in Preparation of Orally Disintegrating Tablets
  • 4 Aug 2026
  • Drug Development and Industrial Pharmacy
Chemical aspects of controlled cisplatin release and apoptosis via Nerium oleander latex nano-carriers in breast cancer cells
  • 3 Aug 2026
  • Drug Development and Industrial Pharmacy
Advances in pectin-based bead formation via ionotropic gelation for enhanced drug delivery: a scoping review
  • 1 Aug 2026
  • Drug Development and Industrial Pharmacy
Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis
  • 1 Aug 2026
  • Drug Development and Industrial Pharmacy
Development and Evaluation of Rizatriptan Benzoate Orally Disintegrating Tablets for Migraine Treatment
  • 31 Jul 2026
  • Drug Development and Industrial Pharmacy

FAQs on Drug Development and Industrial Pharmacy